Reporting owner · CIK 0001782135

Mercier Johanna

Visual SEC Form 4 history across 2 companies, 12 transactions and 4 filings.

CC, CAOChief Comm & Corp Aff OfficerGILEAD SCIENCES, INC.
Open-market mix
Latest filingAug 18, 2026, 10:54 PM
Filings4Form 4 records
Buying$00 purchases
Selling$3.9M2 sales
Net value−$3.9MBuys minus sells
Companies23 securities
Most recentAug 17, 2026exercise

Open-market buy performance

90-day forward return on this insider's open-market purchases

90d forward
Forward return is not available yet

We compute this from each buy's stock performance 90 days after the transaction. The price history is still being populated for this insider's their open-market buys, so the average and median will appear here once the daily price refresh has covered the relevant trading days.

Monthly open-market activity

Reported purchase and sale transaction counts

Buys Sells
530-3-5Feb 25Feb 26May 262Aug 26

Net value flow

Buys minus sells

Feb 25
$0
Feb 26
$0
May 26
$0
Aug 26
−$3.9M

Transaction texture

Ownership and ticket size

Average P/S size$1.9M
Median P/S size$1.9M
Direct12
Indirect0
Aug 17, 2026exercise

Filing-only signals

Deterministic matches in this insider's history

Derivative Transactionfiling-context3Direct Ownershipfiling-context12Large Holdings Increaseholdings3Large Holdings Reductionholdings1Large Salesize2Repeat Sellerpattern110b5-1 Detectedfiling-context6

Latest Form 4 facts

Quick context from source filings

Latest transaction

sale at GILEAD SCIENCES, INC. on Aug 17, 2026 valued at $1,583,265.

Review SEC filing
Latest buy

No open-market insider purchase is available.

Latest sale

sale at GILEAD SCIENCES, INC. on Aug 17, 2026 valued at $1,583,265.

Review SEC filing

Associated companies

Visual map of known reporting history

GILDGILEAD SCIENCES, INC.11 transactions · latest Aug 18, 2026, 10:54 PMNBIXNEUROCRINE BIOSCIENCES INC1 transactions · latest May 29, 2026, 10:04 PM
TickerInsiderRoleTypeSharesValueCodeSignals90d returnFiledTrans date
GILDMercier Johanna
CCCAO
exercise10b5-11.89k$0M
Derivative Transaction Direct Ownership 10b5-1 Detected
+4.5%08/1808/17
GILDMercier Johanna
CCCAO
exercise10b5-123.1k$0M
Derivative Transaction Direct Ownership 10b5-1 Detected
+4.5%08/1808/17
GILDMercier Johanna
CCCAO
sale10b5-111.4k-$158MS
Direct Ownership Large Sale Repeat Seller+1
+4.5%08/1808/17
GILDMercier Johanna
CCCAO
sale10b5-116.5k-$227MS
Direct Ownership Large Sale 10b5-1 Detected
+4.5%08/1808/17
GILDMercier Johanna
CCCAO
exercise10b5-11.89k$13.6MM
Direct Ownership 10b5-1 Detected
+4.5%08/1808/17
GILDMercier Johanna
CCCAO
exercise10b5-123.1k$154MM
Direct Ownership 10b5-1 Detected
+4.5%08/1808/17
NBIXMercier Johanna
DIR
grant2.56k$0A
Derivative Transaction Direct Ownership Large Holdings Increase
−3.8%05/2905/27
GILDMercier Johanna
CCCAO
withholding24.8k-$355MF
Direct Ownership
−8.8%02/0502/03
GILDMercier Johanna
CCCAO
grant44.8k$0A
Direct Ownership Large Holdings Increase
−8.8%02/0502/03
GILDMercier Johanna
CCO
withholding45.6k-$447MF
Direct Ownership Large Holdings Reduction
—02/06/202502/04/2025

Mercier Johanna Insider Activity FAQ

SEC Form 4 context

Who is Mercier Johanna?

Mercier Johanna is a reporting owner in SEC Form 4 filings with reporting owner CIK 0001782135.

Which companies has Mercier Johanna reported transactions for?

GILEAD SCIENCES, INC., NEUROCRINE BIOSCIENCES INC

When was Mercier Johanna's latest insider buy?

No open-market insider purchase is available for this period.

When was Mercier Johanna's latest insider sale?

sale at GILEAD SCIENCES, INC. on Aug 17, 2026 valued at $1,583,265.

Where can I see the original SEC filings?

Each transaction row links directly to the source SEC filing so the reported Form 4 details can be reviewed.

Are performance metrics included?

This version does not calculate win rates, forward returns, benchmark-adjusted returns, or high-conviction scores.